Protein Tyrosine Kinase Inhibitors Block Tumor Necrosis Factor-Induced Activation of Nuclear Factor-κB, Degradation of IκBα, Nuclear Translocation of p65, and Subsequent Gene Expression

1998 ◽  
Vol 352 (1) ◽  
pp. 59-70 ◽  
Author(s):  
K. Natarajan ◽  
Sunil K. Manna ◽  
Madan M. Chaturvedi ◽  
Bharat B. Aggarwal
Keyword(s):  
Gene Expression ◽  
Tumor Necrosis Factor ◽  
Tyrosine Kinase ◽  
Tumor Necrosis ◽  
Protein Tyrosine Kinase ◽  
Kinase Inhibitors ◽  
Nuclear Translocation ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Necrosis Factor

Nuclear Factor-κB–Dependent Induction of Interleukin-8 Gene Expression by Tumor Necrosis Factor : Evidence for an Antioxidant Sensitive Activating Pathway Distinct From Nuclear Translocation

Blood ◽  
1999 ◽  
Vol 94 (6) ◽  
pp. 1878-1889 ◽  
Author(s):  
Spiros Vlahopoulos ◽  
Istvan Boldogh ◽  
Antonella Casola ◽  
Allan R. Brasier
Keyword(s):  
Gene Expression ◽  
Tumor Necrosis Factor ◽  
Transcriptional Activation ◽  
Tumor Necrosis ◽  
Nuclear Translocation ◽  
Gene Transfection ◽  
Nuclear Factor Κb ◽  
Interleukin 8 ◽  
Nuclear Factor ◽  
Necrosis Factor

Tumor necrosis factor  (TNF) is a pluripotent activator of inflammation by inducing a proinflammatory cytokine cascade. This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8). In this study, we investigate the role of TNF-inducible reactive oxygen species (ROS) in IL-8 expression by “monocyte-like” U937 histiocytic lymphoma cells. TNF is a rapid activator of IL-8 gene expression by U937, producing a 50-fold induction of mRNA within 1 hour of treatment. In gene transfection assays, the effect of TNF requires the presence of an inducible nuclear factor-κB (NF-κB) (Rel A) binding site in the IL-8 promoter. TNF treatment induces a rapid translocation of the 65 kD transcriptional activator NF-κB subunit, Rel A, whose binding in the nucleus occurs before changes in intracellular ROS. Pretreatment (or up to 15 minutes posttreatment) relative to TNF with the antioxidant dimethyl sulfoxide (DMSO) (2% [vol/vol]) blocks 80% of NF-κB–dependent transcription. Surprisingly, however, DMSO has no effect on inducible Rel A binding. Similar selective effects on NF-κB transcription are seen with the unrelated antioxidants, N-acetylcysteine (NAC) and vitamin C. These data indicate that TNF induces a delayed ROS-dependent signalling pathway that is required for NF-κB transcriptional activation and is separable from that required for its nuclear translocation. Further definition of this pathway will yield new insights into inflammation initiated by TNF signalling.

Nuclear Factor-κB–Dependent Induction of Interleukin-8 Gene Expression by Tumor Necrosis Factor : Evidence for an Antioxidant Sensitive Activating Pathway Distinct From Nuclear Translocation

Blood ◽  
1999 ◽  
Vol 94 (6) ◽  
pp. 1878-1889 ◽  
Author(s):  
Spiros Vlahopoulos ◽  
Istvan Boldogh ◽  
Antonella Casola ◽  
Allan R. Brasier
Keyword(s):  
Gene Expression ◽  
Tumor Necrosis Factor ◽  
Transcriptional Activation ◽  
Tumor Necrosis ◽  
Nuclear Translocation ◽  
Gene Transfection ◽  
Nuclear Factor Κb ◽  
Interleukin 8 ◽  
Nuclear Factor ◽  
Necrosis Factor

Abstract Tumor necrosis factor  (TNF) is a pluripotent activator of inflammation by inducing a proinflammatory cytokine cascade. This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8). In this study, we investigate the role of TNF-inducible reactive oxygen species (ROS) in IL-8 expression by “monocyte-like” U937 histiocytic lymphoma cells. TNF is a rapid activator of IL-8 gene expression by U937, producing a 50-fold induction of mRNA within 1 hour of treatment. In gene transfection assays, the effect of TNF requires the presence of an inducible nuclear factor-κB (NF-κB) (Rel A) binding site in the IL-8 promoter. TNF treatment induces a rapid translocation of the 65 kD transcriptional activator NF-κB subunit, Rel A, whose binding in the nucleus occurs before changes in intracellular ROS. Pretreatment (or up to 15 minutes posttreatment) relative to TNF with the antioxidant dimethyl sulfoxide (DMSO) (2% [vol/vol]) blocks 80% of NF-κB–dependent transcription. Surprisingly, however, DMSO has no effect on inducible Rel A binding. Similar selective effects on NF-κB transcription are seen with the unrelated antioxidants, N-acetylcysteine (NAC) and vitamin C. These data indicate that TNF induces a delayed ROS-dependent signalling pathway that is required for NF-κB transcriptional activation and is separable from that required for its nuclear translocation. Further definition of this pathway will yield new insights into inflammation initiated by TNF signalling.

Sign in / Sign up

Export Citation Format

Share Document